New Report
Leveraging Decentralized Clinical Trial Management Systems (dCTMS) to Advance Science: Exploring Challenges related to
the Diffusion of Innovation and its Execution
During the COVID-19 pandemic, drug development received critical emphasis for the rapid development of vaccines. Decentralized clinical trials (DCTs) were necessary for research to be conducted across many locations. Although the use of DCTs play a pivotal role in reshaping healthcare, as technology expands into the digital space, implementation challenges must be
considered.
A working group of experts assembled, during an interactive learning exercise at Conv2X Blockchain in Healthcare 2023 to explore challenges related to the diffusion of innovation among key stakeholders. Common “pain points” of technology and innovative approaches that used a blockchain anchored solution were presented. Experts were divided into three stakeholder groups to discuss stakeholder strategies and priorities for
patients, payers, and pharmaceutical sponsor.
Several themes that can be supported by blockchain technology emerged including:
- Enhanced efficiencies
- Patient experience/demographic diversity
- Data integrity/privacy/security
- Cost-effectiveness
To learn more and stay ahead of the curve, visit https://doi.org/10.30953/bhty.v7.305
Author
Rama Krishna Rao | CEO, Co-Founder, Bloqcube Inc., Bridgewater, New Jersey, United States
View the fully open access issue where research excellence bridges real world market impact at https://blockchainhealthcaretoday.com
ConV2X Emerging Tech Pitch Competition
For details see https://conv2xsymposium.com/pitch-competition - Deadline July 10!
